The New England Journal of Medicine has published findings from the TARGET-CTCA trial, examining how CT heart scans are used in patients with acute chest pain.
The *New England Journal of Medicine* posted details of the TARGET-CTCA trial this week, alongside an accompanying editorial. The trial looks at whether targeted use of computed tomographic coronary angiography (CT coronary angiography — a detailed X-ray scan of the heart’s arteries) affects outcomes for people arriving at hospital with sudden chest pain.
The publication also includes an editorial titled *From Detection to Action in Computed Tomographic Coronary Angiography*, which the journal shared at the European Society of Cardiology Congress under the hashtags #ESCCongress and #Cardiology. The trial found no statistically significant reduction in heart attack or cardiac death compared with standard care, with rates of 7.1% in the CT group versus 7.3% in the usual-care group over approximately three years.
Source: @NEJM